Test May Hold Promise In Predicting Rate of Progression in ALS Patients
Researchers from the Mayo Clinic’s campus in Florida, Emory University, and the University of Florida have reportedly developed a novel protein test that may assist in predicting the rate of disease progression in amyotrophic lateral sclerosis (ALS).
Read More